Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03943641
Other study ID # AC19049
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date May 8, 2019
Est. completion date August 1, 2024

Study information

Verified date December 2023
Source University of Edinburgh
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

At present, there is no treatment for dementia that changes the course of the disease. However, it is now understood that the proteins in dementias such as Alzheimer's disease are present years before someone develops symptoms of dementia. Studies may therefore need to give potential treatments to patients before they develop symptoms of dementia. To do this, researchers need a way of predicting who will go on to develop dementia in the future. There are several ways of doing this, however, many of these methods are costly and difficult to implement at a population level - such as brain imaging, lumbar punctures or psychological tests. In this study, the investigators aim to develop a method of predicting who will go on to develop dementia (and dementia due to Alzheimer's disease) using only the sort of information that a general practitioner would have available to them. To do this, the investigators will develop a dementia prediction model using data from the Secure Anonymised Information Linkage (SAIL) Databank, which contains anonymised primary care, hospital admissions and mortality data for the population of Wales, United Kingdom (UK). They will then go on to test how well it performs in an external dataset, such as the UK's Clinical Practice Research Datalink (CPRD).


Description:

To date, no dementia drugs have shown a disease-modifying effect in clinical trials. It is now understood that the pathology underlying Alzheimer's disease is present decades before symptoms become apparent. Starting an intervention only when a patient develops cognitive symptoms, and therefore when there is substantial disease burden, may reduce the chance of any disease-modifying effect. Instead, targeting interventions earlier, when the pathological burden is lower, may increase the likelihood of preventing or delaying dementia onset. Consequently, there is a need for a method that identifies patients who are at an increased risk of developing dementia. This requires the development of a risk prediction model, which utilises multiple predictors in combination to produce individualised estimates of the risk of developing dementia risk over time. An ideal risk prediction model for a population-based application would need to use predictors that are already available to, or readily obtainable by, general practitioners (GPs). Such a predictive tool could be used as a low cost, scalable method of recruiting an 'at risk' group of participants to future trials of risk modification strategies or preventative therapies. Once an effective disease-modifying intervention is identified, clinicians could use the same model to identify at-risk patients who may benefit most from undergoing the intervention. An ideal dementia risk prediction tool would contain only information that is readily available to, or easily obtainable by, clinicians such as General Practitioners (GPs). The investigators aim to develop two 10-year risk prediction models: one to predict all-cause dementia and one to predict Alzheimer's disease dementia, in UK adults aged 60-79 years, using only predictors that are routinely available to GPs. They will develop the model using data from the Secure Anonymised Information Linkage (SAIL) Databank, which is composed of anonymised, linked primary care, hospital admissions and mortality data for the population of Wales, UK. The investigators will then go on to externally validate their dementia risk prediction models in an external dataset, such as the UK's Clinical Practice Research Datalink (CPRD). They will also validate an existing, published study using data from the The Health Improvement Network (THIN) (Walters et al. 2016) using this external dataset, allowing us to compare the performance of the models.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 400000
Est. completion date August 1, 2024
Est. primary completion date May 8, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 79 Years
Eligibility Inclusion Criteria: - Registered with a SAIL practice before 2008 - Aged between 60-79 during the study window (1st January 2008 to 31st December 2017) - Aged 60-79 years by January 2008 Exclusion Criteria: - Deprivation quintile missing for the start of follow-up (deprivation scores will probably not be missing at random) - All-cause dementia code in any dataset prior to 1st January 2008 (i.e. dementia diagnosis at baseline)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
This is not an intervention study
This study is based on retrospective analysis of linked routinely-collected healthcare data

Locations

Country Name City State
United Kingdom Usher Institute, University of Edinburgh Edinburgh Midlothian

Sponsors (2)

Lead Sponsor Collaborator
University of Edinburgh Keele University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Dementia Development of dementia during follow-up 10 years
Primary Alzheimer's disease Development of Alzheimer's disease dementia during follow-up 10 years
See also
  Status Clinical Trial Phase
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT03378245 - Telemedicine-based, Multidisciplinary-team, Intervention to Reduce Unnecessary Hospitalizations N/A
Recruiting NCT04871698 - On Site Sensors Monitoring Impacts of Cognitive Decline on ADLs
Active, not recruiting NCT05847153 - MASC: Reducing Stress for Caregivers N/A
Recruiting NCT04863859 - Persons With Dementia and Their Extended Family Caregivers
Active, not recruiting NCT05529277 - Implementing Dementia Care Management Into Routine Care in the Region Siegen-Wittgenstein
Active, not recruiting NCT03631069 - Detecting Dementia in the Retina Using Optical Coherence Tomography
Not yet recruiting NCT06047340 - Feasibility Study of Game Technology in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease N/A
Terminated NCT03682874 - Identifying Novel Aging Targets for Treatment of Delirium
Completed NCT03907748 - Home-based Family Caregiver-delivered Music and Reading Interventions for People With Dementia N/A
Completed NCT04058886 - Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers N/A
Not yet recruiting NCT05606445 - Surface EMG to Measure Paratonia in Dementia
Recruiting NCT04308512 - Care Coordination System for People With Dementia Phase 1/Phase 2
Not yet recruiting NCT05245903 - Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
Not yet recruiting NCT06396377 - Interest of the Reborn® Doll as a TO in the Care of Residents With Alzheimer's Disease or a Related Disorder N/A
Recruiting NCT03472482 - Optical Coherence Tomography in Cerebral Amyloidosis
Recruiting NCT04313582 - Feasibility of the SmartPrompt for Improving Everyday Function in Dementia N/A
Recruiting NCT05315895 - The Dampness Syndrome of Chinese Medicine Cohort Study
Completed NCT04428112 - Rural Dementia Caregiver Project N/A
Completed NCT04462029 - A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers Early Phase 1